CytomX Therapeutics Lands $31,000,000 Series B Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a920a449-be51-4417-bc94-461c8074e237&Preview=1
Date
7/31/2012
Company Name
CytomX Therapeutics
Mailing Address
650 Gateway Blvd South San Francisco, CA 94080
Company Description
CytomX Therapeutics is an early stage, privately-funded biotechnology company developing Probodies, proteolytically-activated antibodies.
Website
http://www.cytomx.com
Transaction Type
Venture Equity
Transaction Amount
$31,000,000
Transaction Round
Series B
Proceeds Purposes
Proceeds from the expanded Series B financing round will support the advancement of the company’s lead programs toward the clinic and the execution on broad business development activities aimed at the formation of key partnerships in oncology and inflammatory disease.
M&A Terms
Venture Investor
Canaan Partners
Venture Investor
Third Rock Ventures
Venture Investor
Roche Venture Fund